Both in Pharmaceuticals
Skye Bioscience vs Processa Pharmaceuticals
Over the past year SKYE returned −89.3% and PCSA returned −79.6%; their daily moves had a correlation of -0.02.
SKYE −89.3% PCSA −79.6%Growth of $1, one year, split-adjusted
| Metric | SKYE | PCSA |
|---|---|---|
| Price | $1.28 | $1.89 |
| Market cap | $5.7M | $5.3M |
| Today | −2.29% | 0.00% |
| 1 month | −20.0% | +16.7% |
| 6 months | −80.6% | −25.9% |
| Year to date | −78.7% | −34.4% |
| 1 year | −89.9% | −80.6% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $9.9M | $196.3K |
| Dividend yield | — | — |
| Volatility (60d) | 616.8% | 90.1% |
| Short % of float | 0.6% | 2.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).